Neurobiologic Advances from the Brain Disease Model of Addiction.

  title={Neurobiologic Advances from the Brain Disease Model of Addiction.},
  author={Nora D. Volkow and George F. Koob and A. Thomas Mclellan},
  journal={The New England journal of medicine},
  volume={374 4},
This article reviews scientific advances in the prevention and treatment of substance-use disorder and related developments in public policy. [] Key Method 5274, Bethesda, MD 20892, or at nvolkow@ nida . nih . gov.

Figures from this paper

Brain Change in Addiction as Learning, Not Disease.

The brain disease model has also legitimized the role of doctors and other medical professionals in addiction treatment and driven research on new drugs to combat addiction, and it has been used to advocate for access to treatment and care rather than segregation and punishment.

Drug addiction: An affective-cognitive disorder in need of a cure


There is little evidence, at present, to suggest that promulgation of the BDMA will reduce the stigma of addictive disorders and that it may, in actuality, reduce perceived self-efficacy in individuals tackling their addictions.

Value, drug addiction and the brain.

Addictive disorders such as brain diseases: Analysis of the evidence and practical implications

In the last decades, neuroscientific research has supported the fact that addictions are diseases of the brain such as epilepsy or Parkinson’s disease. The punitive approach to manage addictions has

Addiction and the Brain: Development, Not Disease

The brain disease model of addiction is flawed because brain changes in addiction are similar to those generally observed when recurrent, highly motivated goal seeking results in the development of deep habits, Pavlovian learning, and prefrontal disengagement.

Drug overdose deaths, addiction neuroscience and the challenges of translation

It is shown how addiction neuroscience turned to long-term memory to explain the chronicity of addiction and persistent relapses long after neurochemical traces have left the body.

Vulnerability to addiction

Addiction and the Concept of Disorder, Part 1: Why Addiction is a Medical Disorder

This two-part analysis analyzes Marc Lewis’s arguments against the brain-disease view of substance addiction and for a developmental-learning approach that demedicalizes addiction and defends the view that substance addiction is in fact a medical disorder and a brain disorder.



The Brain on Drugs: From Reward to Addiction

Genes and Addictions

Genetic studies and other analyses clarifying the origins of addiction help destigmatize addiction, leading to more prompt treatment, and knowledge of genetic factors in etiology and treatment response may enable the individualization of prevention and treatment, as well as the identification of new therapeutic targets.

Neurobiology of craving, conditioned reward and relapse.

  • F. Weiss
  • Psychology, Biology
    Current opinion in pharmacology
  • 2005

Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications

Functional neuroimaging studies conducted in the past decade that have expanded the understanding of the involvement of the PFC in drug addiction are focused on.

New Developments in Behavioral Treatments for Substance Use Disorders

Recent developments in understanding of the mechanisms of treatment effects, the incorporation of technology into the delivery of current treatments and development of novel applications to support relapse prevention, as well as the inclusion of neurocognitive approaches to target the automatic and higher-order processes underlying addictive behaviors are highlighted.

Reducing substance use during adolescence: a translational framework for prevention

This review will highlight what is known about how factors that increase vulnerability to addiction, including developmental stage, exposure to early life adversity, drug exposure, and genetic predisposition, impact the development of relevant systems.

Dopamine and reward: The anhedonia hypothesis 30 years on

  • R. Wise
  • Psychology, Biology
    Neurotoxicity Research
  • 2009
The anhedonia hypothesis was intended to draw the attention of psychiatrists to the growing evidence that dopamine plays a critical role in the objective reinforcement and incentive motivation associated with food and water, brain stimulation reward, and psychomotor stimulant and opiate reward.

Determinants of Early Alcohol Use In Healthy Adolescents: The Differential Contribution of Neuroimaging and Psychological Factors

With up to 26% of explained variance, the interrelation of reward-related personality traits, behavior, and neural response patterns may convey risk for later alcohol abuse in adolescence, and thus may be identified as a vulnerability factor for the development of substance use disorders.

The Genetics, Neurogenetics and Pharmacogenetics of Addiction

The basis for heritable variation in addiction is revisited before reviewing the most replicable candidate gene findings and emerging signals from genomewide association studies for alcohol, nicotine and cannabis addictions.